Literature DB >> 2672020

Systemic bacillus Calmette-Guerin infection in patients treated by intravesical BCG therapy for superficial bladder cancer.

A Steg1, C Leleu, B Debré, L Boccon-Gibod, D Sicard.   

Abstract

Among 169 patients treated for superficial bladder tumors with intravesical instillations of 150 mg BCG-Pasteur, five developed BCG-itis--a severe systemic infection with bronchopulmonary lesions and granulomatous hepatitis. In four cases, the complication appeared early during treatment (after three, six, six and eight instillations respectively). In one case, BCG-itis appeared 6 months after completion of 2 years monthly maintenance therapy. In addition to pulmonary basal infiltration and granulomatous hepatitis, intramedullary granulomatosis was observed. In three patients, the role of trauma has to be considered, as BCG-itis appeared after a traumatic instillation with bleeding. All patients were cured by combined treatment with Rifampicin, Isoniazid and Prednisolone.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2672020

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN: 0361-7742


  6 in total

1.  Systemic effects of intravesical BCG treatment.

Authors:  B Little; M R A Young; R Convery
Journal:  Ir J Med Sci       Date:  2002 Jul-Sep       Impact factor: 1.568

Review 2.  Intravesical therapy for urothelial carcinoma of the urinary bladder: a critical review.

Authors:  Daher C Chade; Shahrokh F Shariat; Guido Dalbagni
Journal:  Int Braz J Urol       Date:  2009 Nov-Dec       Impact factor: 1.541

3.  Pulmonary tuberculosis due to bacille Calmette-Guérin.

Authors:  D Kirsten; U Rieger; K H Schröder; A Böhle; H Magnussen
Journal:  Clin Investig       Date:  1993-10

4.  Study on enhancement of fibronectin-mediated bacillus Calmette-Guérin attachment to urinary bladder wall in rabbits.

Authors:  Zhou-Jun Shen; Yi Wang; Guo-Qing Ding; Chun-Wu Pan; Rong-Ming Zheng
Journal:  World J Urol       Date:  2007-07-13       Impact factor: 4.226

Review 5.  Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.

Authors:  María Asunción Pérez-Jacoiste Asín; Mario Fernández-Ruiz; Francisco López-Medrano; Carlos Lumbreras; Ángel Tejido; Rafael San Juan; Ana Arrebola-Pajares; Manuel Lizasoain; Santiago Prieto; José María Aguado
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889

6.  Mycotic Aneurysm after Bacillus Calmette-Guérin Treatment: Case Report and Review of the Literature.

Authors:  Nathaniel D Coddington; Jesse K Sandberg; Chen Yang; Jennifer K Sehn; Eric H Kim; Seth A Strope
Journal:  Case Rep Urol       Date:  2017-02-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.